Search companies

Live

Tuesday, 17 November 2026 · 580 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Nanosonics Wins Second FDA Clearance, Expanding CORIS Endoscope Range

NAN: $2.78 -2.46% · MC: $841M

Nanosonics has secured a second FDA clearance for CORIS, extending the system to additional endoscopes, including high-volume colonoscopes and gastroscopes. The clearance builds on earlier regulatory approvals and advances the company’s planned US launch and broader effort to expand CORIS indications.

Source announcements: 2026-11-11 09:45 to 2026-11-11 09:45 Sydney time
Story updated 2026-11-11 09:51 Sydney time
SourcesNanosonics CORIS secures second FDA 510(k) clearance
Comments